Congenital muscular dystrophy with complete laminin-α2-deficiency, cortical dysplasia, and cerebral white-matter changes in children

Journal of Child Neurology

Volumn 13, Issue 6, 1998, Pages 253-256

  Tsao, Chang Yong ^a,b   Mendell, Jerry R ^a   Rusin, Jerome ^a   Luquette, Mark ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHALIN; DYSTROPHIN; LAMININ;

ARTICLE; BRAIN DISEASE; CASE REPORT; CHILD; CLINICAL FEATURE; DYSPLASIA; EYE DISEASE; FEMALE; HUMAN; MALE; MICROGYRIA; MUSCULAR DYSTROPHY; OCCIPITAL LOBE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; WALKER WARBURG SYNDROME; WHITE MATTER;

EID: 0031659647     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389801300602     Document Type: Article

References (26)

1. Fukuyama Y, Kawazura M, Haruna H: A peculiar form of congenital muscular dystrophy: Report of 15 cases. Pediatr Univ Tokyo 1960;4:5-8.
2. Hayashi YK, Engvall E, Arikawa-Hirasawa E, et al: Abnormal localization of laminin subunits in muscular dystrophy. J Neurol Sci 1993;119:53-64.
3. Toda T, Segawa M, Nomura Y, et al: Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet 1993;5:283-286.
4. Sunada Y, Edgar TS, Lotz BP, et al: Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 1995;45:2084-2089.
5. Vainzof M, Marie SKN, Reed UC, et al: Deficiency of merosin (laminin M or α2 ) in congenital muscular dystrophy associated with cerebral white matter alterations. Neuropediatrics 1995;26: 293-297.
6. Minetti C, Bado M, Morreale G, et al: Distribution of muscle basal lamina in congenital muscular dystrophy with merosin deficiency. Neurology 1996;46:1354-1358.
7. Hillaire D, Leclerc A, Faure S, et al: Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994;3:1657-1661.
8. Burgeson RE, Chiquet M, Deutzmann R, et al: A new nomenclature for the laminins. Matrix Biol 1994;14:209-211.
9. Sanes JR, Engvall R, Butkowski R, Hunter DD: Molecular heterogeneity of basal laminae: Isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 1990;111:1685-1699.
10. Engvall E, Earwicker D, Day A, et al: Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite-promoting factor of RN22 schwannoma cells. Exp Cell Res 1992;198:115-123.
11. Matsumura K, Campbell KP: Dystrophin-glycoprotein complex: Its role in the pathogenesis of muscular dystrophy. Neuromuscul Disord 1993;3:109-118.
12. Tomé FMS, Evangelista T, Leclerc A, et al: Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 1994;317: 351-357.
13. Nonaka I, Miyoshino S, Miike T: An electron microscopical study of the muscle in congenital muscular dystrophy. Kumamoto Med J 1972;25:68-82.
14. Philpot J, Topaloglu H, Pennock J, Dubowitz V: Familial concordance of brain magnetic resonance imaging changes in congenital muscular dystrophy. Neuromuscul Disord 1995;5:227-231.
15. Reed UC, Marie SKN, Vainzof M, et al: Congenital muscular dystrophy with cerebral white matter hypodensity. Correlation of clinical features and merosin deficiency. Brain Dev 1996;18:53-58.
16. Dubowitz V, Fardeau M: Workshop report. Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. The Netherlands, 22-24 April, 1994. Neuromuscul Disord 1995; 5:253-258.
17. Yamashita Y, Ohtaki E, Matsuishi T, et al: Merosin-negative non-Fukuyama-type congenital muscular dystrophy: A case report. Brain Dev 1996;18:131-134.
18. Vuolteenaho R, Nissinen M, Sainio K, et al: Human laminin M chain (merosin): Complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124:381-394.
19. Fukuyama Y, Osawa M, Suzuki H: Congenital progressive muscular dystrophy of the Fukuyama type: Clinical, genetic and pathological considerations. Brain Dev 1981;3:1-29.
20. Takada K, Nakamura H, Tanaka J: Cortical dysplasia in congenital muscular dystrophy with central nervous involvement (Fukuyama type). J Neuropathol Exp Neurol 1984;43:395-407.
21. Aida N, Tamagawa K, Takada K, et al: Brain MRI in Fukuyama congenital muscular dystrophy. AJNR Am J Neuroradiol 1996;17:605-613.
22. Parano E, Pavone L, Fiumara A, et al: Congenital muscular dystrophies: Clinical review and proposed classification. Pediatr Neurol 1995;13:97-103.
23. Voit T, Sewry CA, Meyer K, et al: Preserved merosin M-chain (or Iaminin-α2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy. Neuropediatrics 1995;26:148-155.
24. Haltia M, Leivo I, Somer H, et al: Muscle-eye-brain disease: A neuropathological study. Ann Neurol 1997;41:173-180.
25. Leyten QH, Gabreels FJM, Renier WO, terLaak HJ: Congenital muscular dystrophy: A review of the literature. Clin Neurol Neurosurg 1996;98:267-280.
26. Sewry CA, Philpot J, Sorokin LM, et al: Diagnosis of merosin (laminin-2)-deficient congenital muscular dystrophy by skin biopsy. Lancet 1996;347:582-584.